T-REX 2X Long AXTI Daily Target ETF (AXTU)
Live price chart, market sentiment, and community perspectives for T-REX 2X Long AXTI Daily Target ETF (CBOE: AXTU).
Live price chart, market sentiment, and community perspectives for T-REX 2X Long AXTI Daily Target ETF (CBOE: AXTU).
On our trading desk, looking at the T-REX 2X Long AXTI Daily Target ETF (AXTU) launched by REX Shares and Tuttle Capital Management in May 2026, the velocity of capital destruction has been staggering. Seeing the 52-week high at $40.37 collapse toward single digits and forcing a 1:10 reverse stock split highlights why 2x leveraged daily target ETFs on volatile semiconductor substrate players like AXTI cannot be held as multi-week swing positions without compounding decay eating your principal alive.
As a risk manager tracking leveraged products under ETF Opportunities Trust, AXTU represents a textbook case of path dependency. With a 1.50% expense ratio and total assets hovering near $5.51M, the fund's daily reset mechanism makes it exceptionally hazardous during broader market pullbacks in advanced semiconductor supply chains. The July 2026 supplement confirming the 1:10 reverse split underscores the severe downward trajectory from its initial issuance.
When evaluating quantitative structures like AXTU for our portfolio models, one must focus on the underlying asset's structural beta to indium phosphide and gallium wafer demand. AXTI provides foundational materials for optoelectronics, but doubling down on its daily performance via a 2x ETP introduces severe volatility drag. If you aren't trading intraday liquidity and managing delta hour by hour, the structural erosion will systematically drain your position.
In structuring our options overlay strategies for monthly contracts on AXTU, we treat the instrument purely as a short-term tactical vehicle. Because the fund seeks 200% of AXTI's daily performance and nothing more, holding through high-volatility gaps in the materials sector is an unhedged disaster. Our protocol mandates flat exposure by the closing bell to avoid overnight gap risk compounded by the 2x multiplier.
From a quantitative perspective, AXTU's performance metrics show a classic decay profile. With volume frequently fluctuating around tens of thousands of shares and net assets under $6 million, liquidity risk is a primary concern. The gap between its $40.37 peak and subsequent lows down toward the $6 to $15 range highlights the lethal combination of underlying stock volatility and compounding leverage leverage risk.
Explore plasma cleansing, somatic organ swaps, and BCI.